siRNA-mediated CCNA2 knockdown confirmed this observation by right shifting the IC50 of response to prexasertib in NCI-H520 cells (Figure 13B) as well as in the ovarian tumor line OVCAR3 (Figure 13C). This evidence concerns the gene CCNA2 and ovarian neoplasm.